Cargando…

From breakthrough to blockbuster : the business of biotechnology /

Beginning in the 1970s, several scientific breakthroughs promised to transform the creation of new medicines. As investors sought to capitalize on these Nobel Prize-winning discoveries, the biotech industry grew to thousands of small companies around the world. Each sought to emulate what the major...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autores principales: Drakeman, Donald L. (Autor), Drakeman, Lisa Natale (Autor), Oraiopoulos, Nektarios (Autor)
Otros Autores: Ciulla, Chris Andrew, 1975- (Narrador)
Formato: Electrónico Audiom
Idioma:Inglés
Publicado: [Place of publication not identified] : Ascent Audio, 2022.
Edición:[First edition].
Temas:
Acceso en línea:Texto completo (Requiere registro previo con correo institucional)

MARC

LEADER 00000cim a22000007i 4500
001 OR_on1342793566
003 OCoLC
005 20231017213018.0
006 m o h
007 sz zunnnnnuneu
007 cr nnannnuuuuu
008 220830s2022 xx nnnn o h n eng d
040 |a ORMDA  |b eng  |e rda  |e pn  |c ORMDA  |d OCLCF  |d OCLCO 
020 |a 9781663720757  |q (electronic audio bk.) 
020 |a 1663720754  |q (electronic audio bk.) 
029 1 |a AU@  |b 000072719350 
035 |a (OCoLC)1342793566 
037 |a 9781663720757  |b O'Reilly Media 
050 4 |a HD9999.B442 
082 0 4 |a 338.4/76606  |2 23/eng/20220830 
049 |a UAMI 
100 1 |a Drakeman, Donald L.,  |e author. 
245 1 0 |a From breakthrough to blockbuster :  |b the business of biotechnology /  |c Donald L. Drakeman, Lisa N. Drakeman, and Nektarios Oraiopoulos. 
250 |a [First edition]. 
264 1 |a [Place of publication not identified] :  |b Ascent Audio,  |c 2022. 
300 |a 1 online resource (1 audio file (07 hr., 01 min.)) 
306 |a 070100 
336 |a spoken word  |b spw  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
344 |a digital  |2 rdatr 
347 |a audio file  |2 rdaft 
511 0 |a Read by Chris Andrew Ciulla. 
520 |a Beginning in the 1970s, several scientific breakthroughs promised to transform the creation of new medicines. As investors sought to capitalize on these Nobel Prize-winning discoveries, the biotech industry grew to thousands of small companies around the world. Each sought to emulate what the major pharmaceutical companies had been doing for a century or more, but without the advantages of scale, scope, experience, and massive resources. Biotech companies have met the challenge by creating nearly 40% more of the most important treatments for previously unmet medical needs. Moreover, they have done so with much lower overall costs. From Breakthrough to Blockbuster focuses on both the companies themselves and the broader biotech ecosystem that supports them. It paints a portrait of the crucial roles played by academic research, venture capital, contract research organizations, the capital markets, and pharmaceutical companies, demonstrating how a supportive environment enabled the entrepreneurial biotech industry to create novel medicines with unprecedented efficiency. In doing so, it also offers insights for any industry seeking to innovate in uncertain and ambiguous conditions. 
588 0 |a Online resource; title from title details screen (O'Reilly, viewed August 30, 2022). 
590 |a O'Reilly  |b O'Reilly Online Learning: Academic/Public Library Edition 
650 0 |a Biotechnology industries. 
650 6 |a Bio-industries. 
650 7 |a Biotechnology industries  |2 fast 
655 4 |a Downloadable audio books. 
655 7 |a Audiobooks  |2 fast 
655 7 |a Audiobooks.  |2 lcgft 
655 7 |a Livres audio.  |2 rvmgf 
700 1 |a Ciulla, Chris Andrew,  |d 1975-  |e narrator. 
700 1 |a Drakeman, Lisa Natale,  |e author. 
700 1 |a Oraiopoulos, Nektarios,  |e author. 
856 4 0 |u https://learning.oreilly.com/library/view/~/9781663720757/?ar  |z Texto completo (Requiere registro previo con correo institucional) 
994 |a 92  |b IZTAP